Gallstone disease
Template:DiseaseDisorder infobox
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Synonyms and keywords: Cholecystolithiasis, choleliths, cholelithiasis, biliary colic, gall stones, gallbladder calculus.
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Gallstone disease is the presence of gallstones (cholelithiasis) within the gallbladder —chole- means “bile”, lithia means “stone”, and -sis means “process”. Gallstones are crystalline bodies formed within the body by concretion of normal or abnormal bile components. Gallstones can occur anywhere within the biliary tree, including the gallbladder and the common bile duct. Obstruction of the common bile duct is called choledocholithiasis, obstruction of the biliary tree can cause jaundice and obstruction of the outlet of the pancreatic exocrine system can cause pancreatitis.
Historical Perspective
Humans have a long history with gallstones with the earliest recording being noted at least 7000 years ago. Autopsies performed on the earliest mummies in Egypt were discovered to have gallstones. Gallstones became easier to visualize in 1895 with the introduction of the plain x-ray film. In 1924 and 1970, IV cholecystography and percutaneous transhepatic cholangiography were developed respectively.
Classification
Gallstone disease may be classified according to the chemical analysis of gallstone. In this way, there are 3 subtypes: pure cholesterol, pure bilirubin stones and mixed.
Pathophysiology
Studies have shown that gallstone formation is mostly due to bile supersaturation. In the United States, patients that present with gallbladder stones mostly have cholesterol stones. Cholesterol stones form when the concentration of cholesterol in the bile is much higher than the concentration of cholesterol that can be dissolved in the bile. Normally cholesterol is metabolized in the body and excess cholesterol is disposed of in the bile. There is a balance between pronucleating (crystallization-promoting) and antinucleating (crystallization-inhibiting) forces, so that gallstones don’t form. When pronucleating forces take the upper hand, gallstones will form. On the other hand, moderate intake of wine and the consumption of whole grain bread may decrease the risk of developing gallstones.
Causes
Common causes of gallstone disease include increasing age, oral contraceptive pills, pregnancy, diabetes, and obesity. Life threatening causes include conditions causing hepatic and biliary cirrhosis.
Differentiating Gallstone disease from Other Diseases
Gallstone disease must be differentiated from other diseases that cause right upper quadrant pain including gastroesophageal reflux disorder, peptic ulcer disease, hepatitis, sphincter of Oddi dysfunction,appendicitis, bile duct stricture, chronic pancreatitis, irritable bowel syndrome, ischemic heart disease, pyelonephritis, ureteral calculi and complications of gallstone disease include: acute cholecystitis, choledocholithiasis, acute pancreatitis, and acute cholangitis.
Epidemiology and Demographics
The third National Health and Nutrition Examination Survey found that 630 per 100,000 and 1420 per 100,000 men and women aged 20 to 74 respectively in the United States had gallstone disease. In the United States, every year about 1-3% (3 to 9 million people/year) of the population develop gallstones. Gallstone disease has an overall higher incidence in females than males of the Caucasian, Hispanic and Native American nations. Whilst a lower incidence was found in Eastern European, African American, and Japanese populations.
Risk Factors
Common risk factors in the development of gallstone disease include age, sex, pregnancy, and oral contraceptives and estrogen replacement therapy. Less common risk factors include rapid weight loss, prolonged total parenteral nutrition and hepatic and biliary cirrhosis.
Screening
Periodic screening for gallstones is not currently indicated. However, it has been suggested that screening diabetic patients for gallstones and treating them earlier is good practice for avoiding a future cholecystectomy or possible complications.
Natural History, Complications, and Prognosis
Gallstone disease patients should not undergo an elective cholecystectomy until symptoms develop, since almost 55% of patients will remain asymptomatic. Also, the complications of asymptomatic gallstones are almost negligible unless symptoms develop. The complications of gallstone disease include acute cholecystitis, obstructive jaundice, acute cholangitis and acute pancreatitis. The prognosis after laparoscopic cholecystectomy is excellent with morbidity and mortality rates being as low as 0.5 and 10% respectively.
Diagnostic Study of Choice
The best modality for detecting gallstones is a transabdominal ultrasound (TAUS). Patients who present with right upper quadrant pain are suspected of having gallstone disease. The patients symptoms are usually accompanied by a normal physical examination and normal laboratory results including those for leukocytosis and pancreatic enzyme levels. In obese patients, or patients where imaging is practically difficult an esophageal ultrasound (EUS) with high sensitivity may be used.
History and Symptoms
Gallstone disease can manifest in a number of ways. Most patients have a history of obesity, multiple pregnancies, use of oral contraceptive pills, age of 40 years old and over, female and of Caucasian or Native American race. Some patients may be in a physical state that favors the development of gallstones but don’t develop them, some patients may have gallstones, but are asymptomatic. These gallstones are detected incidentally. Some may have gallstones and experience biliary colic, nausea, vomiting and diarrhea, whilst others will have complications due to gallstones, such as acute cholecystitis and acute pancreatitis.
Physical Examination
Patients with gallstones are usually not ill-appearing and don’t have fever or tachycardia. Physical examination of patients with gallstones is sometimes remarkable for right upper quadrant pain, epigastric tenderness, guarding and jaundice. Symptoms occurs when stones reach more than 8 mm in size. Courvoisier’s sign (a palpable gallbladder on physical examination) may be palpated when the common bile duct becomes obstructed and the gallbladder becomes dilated. This mostly occurs with malignant common bile duct obstruction, but has been reported with gallstone disease.
Laboratory Findings
There are no diagnostic laboratory findings associated with an uncomplicated case of gallstone disease. Laboratory findings are usually normal among patients with uncomplicated gallstone disease, both during asymptomatic periods and during attacks of biliary colic. Abnormal blood tests including (leukocytosis, elevated liver or pancreas tests) suggest the development of a complication of gallstone disease, such as acute cholecystitis, acute cholangitis, or acute pancreatitis.
Imaging findings
Stones are mainly visualised using transabdominal ultrasonography. Echogenic foci that cast acoustic shadows are usually seen. There are other imaging modalities, these include; x-ray, computed tomography, magnetic resonance cholangiopancreatography, esophageal ultrasound, endoscopic retrograde cholangiopancreatography (ERCP), bile microscopy and oral cholecystography.
Other diagnostic studies
Bile microscopy has been largely replaced by transabdominal ultrasound, however it may be helpful in evaluating obese patients. Other tests like upper GI endoscopy for peptic ulcer disease may be indicated depending upon the patient’s symptoms and history to rule out other differential diagnoses.
Treatment
Medical Therapy
Patients with asymptomatic gallstones are usually not treated since the chances of complications developing in the future are low, however, patients with symptomatic gallstones can be treated medically, for example, with ursodeoxycholic acid. However, the mainstay of treatment for gallstone disease is surgically, especially since the introduction of laparoscopic cholecystectomy. Fibrates, including gemfibrozil and fenofibrates are an absolute contraindication in gallstone disease.
Lithotripsy
Occasionally, extracorporeal shock wave lithotripsy can be used to fracture gallstones into small pieces and sand to increase the surface area that is exposed to the bile acids, facilitating dissolution and clearance of the stones. Stone may also be manually extracted or a stent may be placed to relief symptoms of biliary colic. This may be an option in those who refuse or are unfit for surgery, or when medical dissolution therapy has been ineffective.
Surgery
Surgery is the first line treatment option in patients with symptomatic gallstones and willing to undergo surgery or patients with gallstone-related complications or patients that are at risk of gallbladder cancer and having symptomatic recurrent attacks, and diabetic patients. Asymptomatic gallstones are not recommended for surgery.
Primary Prevention
Effective measures for the primary prevention of gallstone disease include diet with sufficient fat and protein, maintaining a low body weight, and avoiding prolonged fasting.
Secondary Prevention
Effective measures for the secondary prevention of symptoms developing in an asymptomatic case or for preventing complications with symptomatic gallstone disease includes bile acid therapy. However, medical therapy of asymptomatic stones is not currently indicated.
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Humans have a long history with gallstones with the earliest recording being noted at least 7000 years ago. Autopsies performed on the earliest mummies in Egypt were discovered to have gallstones. Gallstones became easier to visualize in 1895 with the introduction of the plain x-ray film. In 1924 and 1970, IV cholecystography and percutaneous transhepatic cholangiography were developed respectively.
Historical Perspective
Gallstone disease has been noted as far back as when Egyptian pharaohs ruled. Autopsies performed on mummies found gallstones present within the body cavities.[1]
Landmark Events in the Development of Treatment Strategies
- From 1895 to 1924, plain film was developed to better detect radiopaque stones.[2]
- From 1924 to 1960, contrast media was introduced which inspired the invention of IV cholecystography.
- From then on, in 1970, percutaneous transhepatic cholangiography, scintigraphy, and sonography were invented.
- By 1980, the notion that gallbladder stones could be treated medically was introduced.
References
- ↑ Shaffer EA (2005). “Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?”. Curr Gastroenterol Rep. 7 (2): 132–40. PMID 15802102.
- ↑ Feld R, Kurtz AB, Zeman RK (1991). “Imaging the gallbladder: a historical perspective”. AJR Am J Roentgenol. 156 (4): 737–40. doi:10.2214/ajr.156.4.2003437. PMID 2003437.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Gallstone disease may be classified according to the chemical analysis of gallstone. In this way, there are 3 subtypes: pure cholesterol, pure bilirubin stones and mixed.
Classification
- Gallstone disease may be divided into 3 subtypes according to chemical analysis of gallstones :[1][2]
- Pure cholesterol
- Bilirubin
- Mixed or composite:
- Mixed cholesterol
- Calcium carbonate
- Calcium palmitate
- Calcium phosphate
- Black phosphate
| Gallstones | |||||||||||||||||||||||||||||||||||||||||||
| Pure Cholesterol | Pure Bilirubin | Mixed | |||||||||||||||||||||||||||||||||||||||||
| Mixed cholesterol | Calcium carbonate | Calcium palmitate | Calcium phosphate | Black phosphate | |||||||||||||||||||||||||||||||||||||||
References
- ↑ Cariati A (2015). “Gallstone Classification in Western Countries”. Indian J Surg. 77 (Suppl 2): 376–80. doi:10.1007/s12262-013-0847-y. PMC 4692910. PMID 26730029.
- ↑ Jarrar BM, Al-Rowaili MA (2011). “Chemical composition of gallstones from Al-jouf province of saudi arabia”. Malays J Med Sci. 18 (2): 47–52. PMC 3216212. PMID 22135586.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Studies have shown that gallstone formation is mostly due to bile supersaturation. In the United States, patients that present with gallbladder stones mostly have cholesterol stones. Cholesterol stones form when the concentration of cholesterol in the bile is much higher than the concentration of cholesterol that can be dissolved in the bile. Normally cholesterol is metabolized in the body and excess cholesterol is disposed of in the bile. There is a balance between pronucleating (crystallization-promoting) and antinucleating (crystallization-inhibiting) forces, so that gallstones don’t form. When pronucleating forces take the upper hand, gallstones will form. On the other hand, moderate intake of wine and the consumption of whole grain bread may decrease the risk of developing gallstones.
Pathophysiology
- The most common type of gallstone is a cholesterol stone.[1][2][3][4][5]
- When pronucleating proteins are present, such as mucin, the bile becomes hypersaturated with cholesterol and cholesterol stones form.
- Gallstone disease can also be caused by a lack of motility in the muscular wall of the gallbladder or excessive sphincter contraction, that prevents bile secretion.
- In this way the bile stagnates within the gallbladder and promotes the formation of stones.
Pathogenesis of Specific Stones
- Cholesterol stones are the most common type of gallstone.
- The quantity of cholesterol is balanced within the body.
- Cholesterol is an important organic molecule that is needed for incorporation within cell membranes and to produce steroid hormones in the body.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pigment Stones
- Less commonly, gallstones can be composed of bilirubin and are sometimes referred to as “pigment stones”.[8]
- Bilirubin is a byproduct of red blood cell breakdown and so are usually found in patients with hemoglobin disorders.
- Pigment stones are formed via two main pathways:
- Infection of the biliary tree with bacteria that can release hydrolytic enzymes and form insoluble calcium salts.
- Non-bacterial, non-enzymatic hydrolysis of bilirubin conjugates such as what may happen in patients with Gilbert’s syndrome and chronic hemolysis.
Mixed Stones
- There is a lack of evidence that supports a true pathology to explain how mixed stones are formed.[2]
- However, there have been theories that include a combination of several mechanisms including supersaturation, infection and hypomotility of the gall bladder.
Associated Conditions
The conditions associated with gallstone disease include:[9][10]
- Diabetes mellitus type 2
- Obesity
- Pregnancy
- Gallbladder cancer
- Gallbladder polyps
- Primary sclerosing cholangitis
- Porcelain gallbladder
- Rapid weight loss
- Constipation
- Eating fewer meals
- Low intake of:
Gross Pathology
- On gross pathology, commonly multiple small stones are found and less commonly a solitary stone is seen.[11]

Microscopic Pathology
- On microscopic analysis, characteristic findings include:[12]
- Transmural thickening of the gall bladder wall
- Neutrophilia
References
- ↑ 1.0 1.1 Stinton LM, Shaffer EA (2012). “Epidemiology of gallbladder disease: cholelithiasis and cancer”. Gut Liver. 6 (2): 172–87. doi:10.5009/gnl.2012.6.2.172. PMC 3343155. PMID 22570746.
- ↑ 2.0 2.1 Indar AA, Beckingham IJ (2002). “Acute cholecystitis”. BMJ. 325 (7365): 639–43. PMC 1124163. PMID 12242178.
- ↑ McPhee, Stephen (2014). Pathophysiology of disease : an introduction to clinical medicine. New York: McGraw-Hill Education Medical. ISBN 0071806008.
- ↑ Wang HH, Portincasa P, Wang DQ (2008). “Molecular pathophysiology and physical chemistry of cholesterol gallstones”. Front. Biosci. 13: 401–23. PMID 17981556.
- ↑ European Journal Gastroenterology & Hepatology. 6: 585–593. 1995.
|access-date=requires|url=(help) - ↑ Marschall HU, Einarsson C (2007). “Gallstone disease”. J. Intern. Med. 261 (6): 529–42. doi:10.1111/j.1365-2796.2007.01783.x. PMID 17547709.
- ↑ Strasberg SM (2008). “Clinical practice. Acute calculous cholecystitis”. N. Engl. J. Med. 358 (26): 2804–11. doi:10.1056/NEJMcp0800929. PMID 18579815.
- ↑ Trotman BW (1991). “Pigment gallstone disease”. Gastroenterol. Clin. North Am. 20 (1): 111–26. PMID 2022417.
- ↑ Lv J, Yu C, Guo Y, Bian Z, Yang L, Chen Y, Li S, Huang Y, Fu Y, He P, Tang A, Chen J, Chen Z, Qi L, Li L (2017). “Gallstone Disease and the Risk of Type 2 Diabetes”. Sci Rep. 7 (1): 15853. doi:10.1038/s41598-017-14801-2. PMID 29158491.
- ↑ Ortega RM, et al. (1997). “Differences in diet and food habits between patients with gallstones and controls”. Journal of the American College of Nutrition. 16: 88–95.
|access-date=requires|url=(help) - ↑ Ansert, Sandra (2018). Textbook of diagnostic sonography. St. Louis, MO: Elsevier. ISBN 978-0323353755.
- ↑ Fisher, M. M. (1979). Gallstones. Boston, MA: Springer US. ISBN 1461570662.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Common causes of gallstone disease include increasing age, oral contraceptive pills, pregnancy, diabetes, and obesity. Life threatening causes include conditions causing hepatic and biliary cirrhosis.
Causes
Life Threatening Causes
Life threatening causes of gallstones include:[1]
Most Common Causes
Most common causes of gallstones include:[2][3][4]Closing </ref> missing for <ref> tag[5][6]
Less Common Causes
Less common causes of gallstones include:[2][3][4]
- Fasting
- Hemolytic anemia
- Inflammatory bowel disease
- William’s syndrome
- Ulcerative colitis
- Sickle cell disease
Causes by Organ System
Causes in Alphabetical Order
- Aging
- Alpha thalassemia
- Beta thalassemia
- Biliary cirrhosis
- Caroli disease
- Ceftriaxone
- Chronic liver disease
- Cirrhosis
- Clofibrate
- Clonorchiasis
- Combined oral contraceptive pill
- Crohn’s disease
- Cystic fibrosis
- Diabetes
- Dieting
- Erythropoietic protoporphyria
- Estriol
- Estrone
- Fasting
- Fenofibrate
- Gemfibrozil
- Hemochromatosis
- Hemolytic anemia
- Hereditary elliptocytosis
- Hereditary spherocytosis
- Hormonal contraception
- Hypercalcemia
- Hyperlipoproteinemia type 3
- Infection in the gallbladder
- Lanreotide
- Liver cirrhosis
- Lofibra
- Long term intravenous nutrition
- Low-fibre, high-cholesterol diets
- Fibrates
- Obesity
- Pasireotide
- Pergolide
- Pregnancy
- Proton pump inhibitors
- Pyruvate kinase deficiency
- Rapid weight loss
- Rilpivirine
- Secondary biliary cirrhosis
- Sickle cell anemia
- Sickle cell disease
- Somatostatin
- Somatostatinoma
- Spherocytosis
- Tiagabine
- Ulcerative colitis
- Weight loss surgery
- Williams syndrome
References
- ↑ Heaton KW, Braddon FE, Mountford RA, Hughes AO, Emmett PM (1991). “Symptomatic and silent gall stones in the community”. Gut. 32 (3): 316–20. PMC 1378843. PMID 2013429.
- ↑ 2.0 2.1 Valdivieso V, Covarrubias C, Siegel F, Cruz F (1993). “Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium”. Hepatology. 17 (1): 1–4. PMID 8423030.
- ↑ 3.0 3.1 Alvaro D, Angelico M, Gandin C, Ginanni Corradini S, Capocaccia L (1990). “Physico-chemical factors predisposing to pigment gallstone formation in liver cirrhosis”. J. Hepatol. 10 (2): 228–34. PMID 2332595.
- ↑ 4.0 4.1 Maurer KR, Everhart JE, Ezzati TM, Johannes RS, Knowler WC, Larson DL, Sanders R, Shawker TH, Roth HP (1989). “Prevalence of gallstone disease in Hispanic populations in the United States”. Gastroenterology. 96 (2 Pt 1): 487–92. PMID 2642879.
- ↑ Liu B, Beral V, Balkwill A, Green J, Sweetland S, Reeves G (2008). “Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study”. BMJ. 337: a386. PMC 2500203. PMID 18617493.
- ↑ De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, De Luca C, Pinto G, Lisi D, Capocaccia L (1997). “Gallstones and diabetes: a case-control study in a free-living population sample”. Hepatology. 25 (4): 787–90. doi:10.1002/hep.510250401. PMID 9096577.
Differentiating Gallstone disease from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Gallstone disease must be differentiated from other diseases that cause right upper quadrant pain including gastroesophageal reflux disorder, peptic ulcer disease,hepatitis,sphincter of Oddi dysfunction,appendicitis, bile duct stricture, chronic pancreatitis, irritable bowel syndrome, ischemic heart disease, pyelonephritis, ureteral calculi and complications of gallstone disease include: acute cholecystitis, choledocholithiasis, acute pancreatitis, and acute cholangitis.
Differentiating Gallstone disease from other Diseases
- Gallstone disease can manifest in a variety of clinical forms.
- The presence of biliary colic is an important diagnostic feature to distinguish between gallstones and non-biliary stone disorders.
- Patients who present with biliary colic are more likely to have gallstones detected on imaging. [1]
- However, it is important to note that biliary colic can be concomitant in patients with other biliary disorders such as acute cholecystitis, choledocholithiasis, sphincter of Oddi dysfunction, and functional gallbladder disorder.[2][3]
Differential diagnosis
The differential diagnosis of diseases presenting with abdominal pain, fever and jaundice is discussed below.
Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
To review a differential diagnosis for abdominal pain, click here
References
- ↑ Kraag N, Thijs C, Knipschild P (1995). “Dyspepsia–how noisy are gallstones? A meta-analysis of epidemiologic studies of biliary pain, dyspeptic symptoms, and food intolerance”. Scand. J. Gastroenterol. 30 (5): 411–21. PMID 7638565.
- ↑ Portincasa P, Moschetta A, Palasciano G (2006). “Cholesterol gallstone disease”. Lancet. 368 (9531): 230–9. doi:10.1016/S0140-6736(06)69044-2. PMID 16844493.
- ↑ Center SA (2009). “Diseases of the gallbladder and biliary tree”. Vet. Clin. North Am. Small Anim. Pract. 39 (3): 543–98. doi:10.1016/j.cvsm.2009.01.004. PMID 19524793.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
The third National Health and Nutrition Examination Survey found that 630 per 100,000 and 1420 per 100,000 men and women aged 20 to 74 respectively in the United States had gallstone disease. In the United States, every year about 1-3% (3 to 9 million people/year) of the population develop gallstones. Gallstone disease has an overall higher incidence in females than males of the Caucasian, Hispanic and Native American nations. Whilst a lower incidence was found in Eastern European, African American, and Japanese populations.
Epidemiology and Demographics
Prevalence
The third National Health and Nutrition Examination Survey found that 630 per 100,000 and 1420 per 100,000 men and women aged 20 to 74 respectively in the United States had gallstone disease.[1]
Incidence
- In the United States, every year about 1-3% (3 to 9 million people/year) of the population develop gallstones.[2]
- The incidence of choledocholithiasis is higher internationally, mainly because of parasitic infestation with liver flukes such as Clonorchis sinensis not found in the United States.
Age
- Patients of age groups between 20 – 74 develop gallstone disease.[1]
- The most common age group is between 40-69 years of age.
Race
- Gallstone disease usually affects individuals of the Western Caucasian, Hispanic and Native American races.[3][4][5][6]
- Eastern European, African American and Japanese individuals are less likely to develop Gallstone disease.
| Incidence of Gallstone disease according to race | ||
|---|---|---|
| Race | Gender (percentage incidence per 100,000) | |
| Women | Men | |
| Black | 13.9 | 5.3 |
| Non-Hispanic Caucasian | 16.6 | 8.6 |
| Eastern European | 9.5 | 18.8 |
| Hispanic | 26.7 | 8.9 |
| Pima Indian[7][8] | 73 | 23 |
| Japanese | 4.8 | 1.8 |
Gender
- Females are more commonly affected by gallstone disease than males.[1][9][10][11][12]
- This may be due to increased estrogen levels and the use of oral contraceptive pills within the female population, which increase biliary cholesterol secretion.
- The female to male ratio is approximately 2.5 to 1.
| Incidence of Gallstone disease | ||
|---|---|---|
| Age group | Gender (Per 100,000) | |
| Women | Men | |
| Age 20 – 74 | 1420 | 630 |
Region
- In Japanese men of the Sumo wrestling profession, a high incidence of gallstones was found with an increasing body mass index.[13]
References
- ↑ 1.0 1.1 1.2 Everhart JE, Khare M, Hill M, Maurer KR (1999). “Prevalence and ethnic differences in gallbladder disease in the United States”. Gastroenterology. 117 (3): 632–9. PMID 10464139.
- ↑ Halldestam I, Kullman E, Borch K (2009). “Incidence of and potential risk factors for gallstone disease in a general population sample”. Br J Surg. 96 (11): 1315–22. doi:10.1002/bjs.6687. PMID 19847878.
- ↑ TORVIK A, HOIVIK B (1960). “Gallstones in an autopsy series. Incidence, complications, and correlations with carcinoma of the gallbladder”. Acta Chir Scand. 120: 168–74. PMID 13777615.
- ↑ Zahor A, Sternby NH, Kagan A, Uemura K, Vanecek R, Vichert AM (1974). “Frequency of cholelithiasis in Prague and Malmö. An autopsy study”. Scand. J. Gastroenterol. 9 (1): 3–7. PMID 4453803.
- ↑ Brett M, Barker DJ (1976). “The world distribution of gallstones”. Int J Epidemiol. 5 (4): 335–41. PMID 1010661.
- ↑ Lindström CG (1977). “Frequency of gallstone disease in a well-defined Swedish population. A prospective necropsy study in Malmö”. Scand. J. Gastroenterol. 12 (3): 341–6. PMID 866998.
- ↑ Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA (1970). “Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography”. N. Engl. J. Med. 283 (25): 1358–64. doi:10.1056/NEJM197012172832502. PMID 5481754.
- ↑ Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, Okoliksanyi L, Ricci G, Capocaccia R, Festi D (1995). “Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)”. Am. J. Epidemiol. 141 (2): 158–65. PMID 7817971.
- ↑ Thistle JL, Eckhart KL, Nensel RE, Nobrega FT, Poehling GG, Reimer M, Schoenfield LJ (1971). “Prevalence of gallbladder disease among Chippewa Indians”. Mayo Clin. Proc. 46 (9): 603–8. PMID 5096596.
- ↑ Williams CN, Johnston JL, Weldon KL (1977). “Prevalence of gallstones and gallbladder disease in Canadian Micmac Indian women”. Can Med Assoc J. 117 (7): 758–60. PMC 1880087. PMID 907946.
- ↑ WILBUR RS, BOLT RJ (1959). “Incidence of gall bladder disease in normal men”. Gastroenterology. 36 (2): 251–5. PMID 13620038.
- ↑ Wang HH, Liu M, Clegg DJ, Portincasa P, Wang DQ (2009). “New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation”. Biochim. Biophys. Acta. 1791 (11): 1037–47. doi:10.1016/j.bbalip.2009.06.006. PMC 2756670. PMID 19589396.
- ↑ Kodama H, Kono S, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K, Nishiwaki M, Hamada H, Nishikawa H, Koga H, Ogawa S, Nakagawa K (1999). “Gallstone disease risk in relation to body mass index and waist-to-hip ratio in Japanese men”. Int. J. Obes. Relat. Metab. Disord. 23 (2): 211–6. PMID 10078858.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Common risk factors in the development of gallstone disease include age, sex, pregnancy, and oral contraceptives and estrogen replacement therapy. Less common risk factors include rapid weight loss, prolonged total parenteral nutrition and hepatic and biliary cirrhosis.
Risk Factors
Common Risk Factors
- Common risk factors in the development of gallstone disease include:[1][2][3][4][3][5]
- Age
- Age is the most important risk factor.
- The most common age for developing gallstones was found to be between ages 40 – 69 years.
- Cholelithiasis rarely exists in children unless in a hemolytic state.
- Gender
- A higher incidence is noted in women across all age groups.
- Race
- Gallstone disease is common amongst Pima Indians, North Americans and Chileans. Japanese have the lowest incidence.
- Pregnancy
- Cholesterol gallstone incidence in pregnant women is very common, paarticularly in multiparous women.
- Diabetes Mellitus Type 2
- Uncontrolled diabetes mellitus will cause motility problems in the gallbladder.
- Obesity
- Obesity is related to a high fat or high cholesterol diet.
- Age
Less Common Risk Factors
- Less common risk factorsin the development of gallstone disease include:[6][7][8][9][10]
- Rapidly weight loss and gastric bypass surgery
- Long-term octreotide
- Long-term total parenteral nutrition (TPN)
- Drug induced e.g. Ceftriaxone[11]
- Prolonged fasting
- Presence of Crohn’s disease
- Cystic fibrosis
- Liver cirrhosis
- Extensive bowel resection
- Spinal cord injury
- Use of medications such as
References
- ↑ Barbara L, Sama C, Morselli Labate AM, Taroni F, Rusticali AG, Festi D, Sapio C, Roda E, Banterle C, Puci A (1987). “A population study on the prevalence of gallstone disease: the Sirmione Study”. Hepatology. 7 (5): 913–7. PMID 3653855.
- ↑ Maurer KR, Everhart JE, Ezzati TM, Johannes RS, Knowler WC, Larson DL, Sanders R, Shawker TH, Roth HP (1989). “Prevalence of gallstone disease in Hispanic populations in the United States”. Gastroenterology. 96 (2 Pt 1): 487–92. PMID 2642879.
- ↑ 3.0 3.1 Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA (1970). “Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography”. N. Engl. J. Med. 283 (25): 1358–64. doi:10.1056/NEJM197012172832502. PMID 5481754.
- ↑ Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, Okoliksanyi L, Ricci G, Capocaccia R, Festi D (1995). “Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)”. Am. J. Epidemiol. 141 (2): 158–65. PMID 7817971.
- ↑ Valdivieso V, Covarrubias C, Siegel F, Cruz F (1993). “Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium”. Hepatology. 17 (1): 1–4. PMID 8423030.
- ↑ Maringhini A, Ciambra M, Baccelliere P, Raimondo M, Orlando A, Tinè F, Grasso R, Randazzo MA, Barresi L, Gullo D, Musico M, Pagliaro L (1993). “Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history”. Ann. Intern. Med. 119 (2): 116–20. PMID 8512160.
- ↑ Apstein MD, Dalecki-Chipperfield K (1987). “Spinal cord injury is a risk factor for gallstone disease”. Gastroenterology. 92 (4): 966–8. PMID 3557002.
- ↑ Quigley EM, Marsh MN, Shaffer JL, Markin RS (1993). “Hepatobiliary complications of total parenteral nutrition”. Gastroenterology. 104 (1): 286–301. PMID 8419252.
- ↑ Hussaini SH, Murphy GM, Kennedy C, Besser GM, Wass JA, Dowling RH (1994). “The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones”. Gastroenterology. 107 (5): 1503–13. PMID 7926514.
- ↑ Caroli-Bosc FX, Le Gall P, Pugliese P, Delabre B, Caroli-Bosc C, Demarquay JF, Delmont JP, Rampal P, Montet JC (2001). “Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population”. Dig. Dis. Sci. 46 (3): 540–4. PMID 11318529.
- ↑ Shiffman ML, Keith FB, Moore EW (1990). “Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility”. Gastroenterology. 99 (6): 1772–8. PMID 2227290.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Periodic screening for gallstones is not currently indicated. However, it has been suggested that screening diabetic patients for gallstones and treating them earlier is good practice for avoiding a future cholecystectomy or possible complications.
Screening
- There is no screening program in place for the detection of gallstones at present.[1][2]
- However, it has been suggested that screening diabetic patients for gallstones and treating them earlier is good practice for avoiding a future cholecystectomy or possible complications.
- A Taiwanese study also concluded that annual screening for gallstones could be valuable both medically and economically.
References
- ↑ Chen L, Peng YT, Chen FL, Tung TH (2015). “Epidemiology, management, and economic evaluation of screening of gallstone disease among type 2 diabetics: A systematic review”. World J Clin Cases. 3 (7): 599–606. doi:10.12998/wjcc.v3.i7.599. PMC 4517334. PMID 26244151.
- ↑ Shen HJ, Hsu CT, Tung TH (2015). “Economic and medical benefits of ultrasound screenings for gallstone disease”. World J. Gastroenterol. 21 (11): 3337–43. doi:10.3748/wjg.v21.i11.3337. PMC 4363765. PMID 25805942.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Gallstone disease patients should not undergo an elective cholecystectomy until symptoms develop, since almost 55% of patients will remain asymptomatic. Also, the complications of asymptomatic gallstones are almost negligible unless symptoms develop. The complications of gallstone disease include acute cholecystitis, obstructive jaundice, acute cholangitis and acute pancreatitis. The prognosis after laparoscopic cholecystectomy is excellent with morbidity and mortality rates being as low as 0.5 and 10% respectively.
Natural History, Complications, and Prognosis
Natural History
- Gallstone disease usually develops in the third decade of life, and can start asymptomatically.[1]
- Symptoms of biliary colic may develop such as abdominal pain, fever and, jaundice.
- If left untreated, only 10% of patients with gallstone disease may progress to develop symptoms.
Complications
- Common complications of gallstone disease include:[2]
Prognosis
- Elective cholecystectomy has a mortality rate and morbidity rate of 0.5% and 10% respectively.[3]
- Emergent cholecystectomy has a mortality rate and morbidity rate of 3-5% and 30-50% respectively.
- The risk of developing an incisional hernia after a laparoscopic cholecystectomy is about 8% in patients over 50 years of age.
- Patients with gallstones in the gallbladder have an associated choledocholithiasis (stone in the common bile duct) in 10-15% of the time.
References
- ↑ McSherry CK, Ferstenberg H, Calhoun WF, Lahman E, Virshup M (1985). “The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients”. Ann. Surg. 202 (1): 59–63. PMC 1250837. PMID 4015212.
- ↑ Friedman GD (1993). “Natural history of asymptomatic and symptomatic gallstones”. Am. J. Surg. 165 (4): 399–404. PMID 8480871.
- ↑ Julliard O, Hauters P, Possoz J, Malvaux P, Landenne J, Gherardi D (2016). “Incisional hernia after single-incision laparoscopic cholecystectomy: incidence and predictive factors”. Surg Endosc. 30 (10): 4539–43. doi:10.1007/s00464-016-4790-4. PMID 26895902.
Diagnosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram |X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Lithotripsy | Surgical Management | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
External Links
External Links
- Gallbladder removal – series from Nuggets Medical Encyclopedia
- Diagram of pain radiation
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
